Home
Conditions
Neoplasms by Histologic Type

Clinical trial condition

Neoplasms by Histologic Type

Explore clinical trials studying Neoplasms by Histologic Type. Study availability and eligibility vary by location and protocol.

30,134 public trials 6,478 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms by Histologic Type trial results

Recruiting

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

NCT07109726

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +42 more
Locations: Florida Cancer Specialists - Lake Nona Orlando, Florida, United States

Massachusetts General Hospital Boston, Massachusetts, United States

Mayo Rochester Rochester, Minnesota, United States

Washington Univ. School of Medicine St Louis, Missouri, United States

View all 18 locations

View Trial Details

Recruiting

Immune Profiling of CLL/SLL Treated With First-Line Pirtobrutinib

NCT07428707

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +15 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial

NCT06432036

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations: UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

University of Colorado Anschutz Medical Campus Aurora, Colorado, United States

View Trial Details

Recruiting

Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases

NCT03965234

Conditions: Bone Diseases, Bone Neoplasms, Colonic Diseases, +20 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Recruiting

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

NCT05006716

Conditions: B-cell Malignancy, Blood Protein Disorders, Cardiovascular Diseases, +37 more
Locations: University of Alabama At Birmingham Hospital Birmingham, Alabama, United States

Mayo Clinic Phoenix Phoenix, Arizona, United States

Honor Health Research Institute Scottsdale, Arizona, United States

University of Arizona Cancer Center Tucson, Arizona, United States

View all 115 locations

View Trial Details

Recruiting

BGB-58067 in Newly Diagnosed Glioblastoma Patients With MTAP-Deleted Tumors

NCT07485049

Conditions: Astrocytoma, Glioblastoma, Glioblastoma (GBM), +8 more
Locations: St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States

View Trial Details

Recruiting

Safety, Tolerability, and Preliminary Efficacy of [211At]MABG in Patients With Relapsed or Refractory Neuroblastoma

NCT07767630

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +8 more
Locations: West China Hospital Chengdu, Sichuan, China

View Trial Details

Recruiting

CD19/CD22 CAR-T Consolidation in R/R Aggressive B-Cell Lymphoma After Second-Line Therapy

NCT07779018

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Chinese PLA General Hospital, Beijing, Beijing 100853 Beijing, China

View Trial Details

Recruiting

TRTME: Improving Outpatient Initiation of Medication for Opioid Use Disorder Following Hospitalization

NCT07780097

Conditions: Chemically-Induced Disorders, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations: University of Cincinnati Addiction Sciences Division Cincinnati, Ohio, United States

View Trial Details

Recruiting

A Phase I-II Study Investigating the All-Oral Combination of the Menin Inhibitor SNDX-5613 With Decitabine/Cedazuridine (ASTX727) and Venetoclax in Acute Myeloid Leukemia (SAVE)

NCT05360160

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Neoplasms by Histologic Type

Neoplasms by Histologic Type trial results

Related conditions